Transaktionen anzeigen
Gesundheitswesen

Mosaic Laboratories has been acquired by Caprion HistoGeneX

The shareholders of Mosaic Laboratories have sold the company to Caprion HistoGeneX.

Founded in 2005 by Lisa Dauffenbach and Chris Kerfoot, Mosaic Laboratories is a Lake Forest, California-based leading provider of bio-analytical testing services supporting translational, preclinical and clinical trial studies for a marquee roster of biotech and pharmaceutical clients globally. Mosaic pioneered proprietary multiplex immunohistochemistry (IHC) services that provide a superior ability to evaluate multiple biomarkers in a single tissue section, and has built a reputation among pharmaceutical companies to produce the most vivid IHC biomarker images. Mosaic supports the most rigorous clinical trial programs in the world, thereby impacting the future of patient therapies for cancer and other diseases.

Caprion HistoGeneX is a provider of proteomics and immune monitoring services for the pharmaceutical and biotechnology industry. The company operates two proprietary immune monitoring platforms that offer multiparametric flow cytometry services for functional analyses of innate and adaptive immune responses while its proteomics business unit, as well as gel-free, label-free mass spectrometry (MS), provide comprehensive, quantitative and robust comparative measurement of proteins across large sets of biological samples for the discovery and validation of protein biomarkers.

Oaklins’ team in Los Angeles acted as advisor to the seller in this transaction.

DIENSTLEISTUNG
Verkauf
PARTEIEN

Sprechen Sie mit dem Deal Team

 Adam  Abramowitz

Adam Abramowitz

Managing Director

Los Angeles, Vereinigte Staaten
Oaklins Intrepid
 Jonathan  Bluth

Jonathan Bluth

Managing Director

Los Angeles, Vereinigte Staaten
Oaklins Intrepid

Transaktionen

Nutricare has raised 3.1 million via an entitlement offer
Handel | Gesundheitswesen

Nutricare has raised 3.1 million via an entitlement offer

Nutricare Pty Ltd has raised funds to support its growth strategy.

Mehr erfahren
Gilde Healthcare has invested in Tandarts Today
Private Equity | Gesundheitswesen

Gilde Healthcare has invested in Tandarts Today

Gilde Healthcare has invested in Tandarts Today, a fast-growing dental chain in the Netherlands. The investment will allow Tandarts Today to accelerate its buy-and-build strategy and become a leading dental chain in the Netherlands. Financial details have not been disclosed.

Mehr erfahren
Alcidion (ASX:ALC) has acquired ExtraMed
Gesundheitswesen

Alcidion (ASX:ALC) has acquired ExtraMed

Alcidion (ASX:ALC) has acquired ExtraMed Ltd., a UK provider of patient flow management software that helps address key pain-points for hospital administrative staff.

Mehr erfahren